Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy M Simon

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Molecular Cell|June 28, 2022
An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinomaJin Zhou, Jeremy M Simon, Chengheng Liao, et al.
Cancer Discovery|July 22, 2020
Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast CancerChengheng Liao, Yang Zhang, Cheng Fan, et al.
Elife|November 15, 2021
ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancerWentong Fang, Chengheng Liao, Rachel Shi, et al.
The Journal of Clinical Investigation|April 15, 2024
Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesisCheng Zhang, Miaomiao Yu, Austin J Hepperla, et al.
Frontiers in Immunology|April 11, 2022
BET Protein Inhibition Regulates Macrophage Chromatin Accessibility and Microbiota-Dependent ColitisMichelle Hoffner O'Connor, Ana Berglind, Meaghan M Kennedy Ng, et al.
Oncogene|May 16, 2022
TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in miceSamera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
Elife|October 11, 2023
RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathyJulie C Necarsulmer, Jeremy M Simon, Baggio A Evangelista, et al.
Oncogene|August 24, 2022
Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in miceSamera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
Gut|October 16, 2016
Molecular classification of Crohn's disease reveals two clinically relevant subtypesMatthew Weiser, Jeremy M Simon, Bharati Kochar, et al.
The Journal of Pathology|July 4, 2020
A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissueBrittany M Bowman, Stephanie A Montgomery, Travis P Schrank, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Molecular Cell|June 28, 2022
An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinomaJin Zhou, Jeremy M Simon, Chengheng Liao, et al.
Cancer Discovery|July 22, 2020
Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast CancerChengheng Liao, Yang Zhang, Cheng Fan, et al.
Elife|November 15, 2021
ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancerWentong Fang, Chengheng Liao, Rachel Shi, et al.
The Journal of Clinical Investigation|April 15, 2024
Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesisCheng Zhang, Miaomiao Yu, Austin J Hepperla, et al.
Frontiers in Immunology|April 11, 2022
BET Protein Inhibition Regulates Macrophage Chromatin Accessibility and Microbiota-Dependent ColitisMichelle Hoffner O'Connor, Ana Berglind, Meaghan M Kennedy Ng, et al.
Oncogene|May 16, 2022
TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in miceSamera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
Elife|October 11, 2023
RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathyJulie C Necarsulmer, Jeremy M Simon, Baggio A Evangelista, et al.
Oncogene|August 24, 2022
Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in miceSamera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
Gut|October 16, 2016
Molecular classification of Crohn's disease reveals two clinically relevant subtypesMatthew Weiser, Jeremy M Simon, Bharati Kochar, et al.
The Journal of Pathology|July 4, 2020
A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissueBrittany M Bowman, Stephanie A Montgomery, Travis P Schrank, et al.
Pageof 10